Cytosorb Therapy in Cardiac Surgery

Status Completed

Clinical Trial Summary

Cardiopulmonary surgery is associated with inflammatory responses that can lead to systemic inflammatory responses (SIRS), organ dysfunction (MOD) and death especially in patients with endocarditis. Cytokine removal might therefore improve outcomes of patients undergoing cardiac surgery. CytoSorb is a device designed to remove cytokine (IL-6, IL-10, TNFalpha) from the blood to reduce immune reactions. This trial investigates the use of CytoSorb during cardiac surgery in patients with endocarditis at the University Hospital Basel.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04309591
Study type	Observational
Source	University Hospital, Basel, Switzerland
Contact
Status	Completed
Phase
Start date	October 18, 2019
Completion date	December 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05547607` - Clinical and Diagnostic Features of Endocarditis
Completed	`NCT00750373` - Early Surgery Versus Conventional Treatment in Infective Endocarditis	Phase 4
Recruiting	`NCT03690076` - Human Cardiac Mitochondria in Acute Endocarditis and Obesity
Terminated	`NCT01734694` - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients	Phase 4
Terminated	`NCT00995384` - Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis	N/A
Recruiting	`NCT05142891` - Renal Tolerance of Amoxicillin and Cloxacillin Combination
Recruiting	`NCT05703022` - Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis.	N/A
Completed	`NCT01431326` - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed	`NCT03377465` - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis	N/A
Recruiting	`NCT03892174` - Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)	N/A
Completed	`NCT03695861` - Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves	N/A
Recruiting	`NCT02759978` - Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
Completed	`NCT00709358` - Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections	Phase 4
Terminated	`NCT03148756` - Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis	Phase 2
Enrolling by invitation	`NCT05156437` - Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)	Phase 4
Recruiting	`NCT06107309` - Suppressive Antibiotic Therapy for Endocarditis
Completed	`NCT02251262` - Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection	N/A
Recruiting	`NCT03112356` - The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials	Phase 4
Completed	`NCT01375257` - Partial Oral Treatment of Endocarditis	Phase 4
Terminated	`NCT00590889` - Artificial Valve Endocarditis Reduction Trial	N/A